Clinical Trials List
2013-02-21 - 2016-02-28
Phase III
Terminated4
ICD-10E11.9
Type 2 diabetes mellitus without complications
ICD-10E13.9
Other specified diabetes mellitus without complications
ICD-9250.00
Diabetes mellitus without mention of complication, Type II [non-insulin dependent type][NIDDM type] [ adult-onset type] or unspecified type, not stated as uncontrolled
-
Trial Applicant
NOVO NORDISK PHARMA (TAIWAN) LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 許瑞旭 Division of Endocrinology
- 劉妙真 Division of Endocrinology
- 林承緯 Division of Endocrinology
- 陳正友 Division of Endocrinology
- 王誌慶 Division of Endocrinology
- Jui-Hung Sun Division of Endocrinology
- Jia-Hong Lin Division of Endocrinology
- Wen-Cong Lu Division of Endocrinology
- 黃瓊慧 Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 吳令怡 Division of Endocrinology
- 李建興 Division of Endocrinology
- 謝昌勳 Division of Endocrinology
- Chih-Tsueng He Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
100 participants
-
Global
4347 participants
